We hypothesized recently that arginine ho- established by medical history, physical examination, analysis of blood cell count, routine biochemical profile, and urinalysis. Their daily food and nutrient intakes were calculated to maintain body weight based on a dietary history and an estimate of the subject's usual level of physical activity. Subjects were encouraged to maintain their customary levels of physical activity but did not participate in competitive sports. The experimental protocol was approved by the Advisory Committee of the CRC. Subjects signed consent forms and were paid for their participation in the study.They consumed the arginine-rich (Arg-rich) diet for 6 days and on the morning of day 7 they received primed, constant intravenous tracer infusions of L-[guanidino-'5N2; 5,5-2H]arginine and L- [5-13C]ornithine. This tracer study was followed immediately by a second 6-day experimental period during which an argnine-free (Arg-free) diet was consumed. Again, on the morning of day 7 an intravenous infusion protocol was conducted as described above. The experimental diet was based on isonitrogenous Arg-rich and Arg-free L-amino acid mixtures, as described (4). The major energy source was given in the form of protein-free wheat starch cookies. The daily intake, prior to the tracer infusion studies, was consumed as three separate meals at 0800, 1200, and 1700 h. Meals were prepared in the CRC by the dietary staff.Tracer Infusion Studies. The isotope-infusion protocol lasted for 8 h. During the first 3 h, the subjects remained in the postabsorptive state (fast state), following their 10-to 12-h overnight fast. This phase was followed immediately by a 5-h fed state during which subjects received small, equal meals at 30-min intervals to supply over this period half of the amino acid intake received on the previous days. The details of procedures that were followed immediately before and during the infusion protocol have been presented (4,8).